Tags |
|
|
Links |
|
|
Just Other Articles - Training - Cost or Investment?
How do you view training and development in your business?
Do you need to quantify and measure it? Is the value you place on developing your staff and management purely monetary or is there a greater benefit to the individual and to the or
Do you need to quantify and measure it? Is the value you place on developing your staff and management purely monetary or is there a greater benefit to the individual and to the or
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ganisation?
In a study carried out by the International Institute of Management Development 80% of respondents were unable to quantify the effect of development. Yet millions of pounds are invested, in management
In a study carried out by the International Institute of Management Development 80% of respondents were unable to quantify the effect of development. Yet millions of pounds are invested, in management
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
development alone, each year in the UK.
It just doesn't add up. It is ingrained in all good businesses to test, measure and know their numbers. So why spend millions without knowing the result.
So what is the value of training? Many organ
It just doesn't add up. It is ingrained in all good businesses to test, measure and know their numbers. So why spend millions without knowing the result.
So what is the value of training? Many organ
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
isations say they now agree that their work force is their greatest asset and so investing in their development is both necessary and worthwhile these organisations place a high value on training. However, some still see training as a neces
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
sary interruption to work and productivity and place very little value upon it.
The fact is that the value of training is and always has been difficult to measure. However we find that in organisations which place a high perceived value up
The fact is that the value of training is and always has been difficult to measure. However we find that in organisations which place a high perceived value up
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
n development the real benefits are far greater than in those organisations which do not.
Changing the perception of training in an organisation is like changing any cultural belief but it can be done by ensuring that the true value of thi
Changing the perception of training in an organisation is like changing any cultural belief but it can be done by ensuring that the true value of thi
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
s work is communicated clearly and openly for all to see.
But as we all know saying something has a value is not enough it has to be demonstrated, so how do we do this? Well quite simply by changing the approach we have to what training an
But as we all know saying something has a value is not enough it has to be demonstrated, so how do we do this? Well quite simply by changing the approach we have to what training an
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
d development is and why we need it.
Here's a thought! Why do training just because everybody says it is the way to develop and motivate yourself and your staff, increase production, keep up with the Jones's what ever reason you think of.
Here's a thought! Why do training just because everybody says it is the way to develop and motivate yourself and your staff, increase production, keep up with the Jones's what ever reason you think of.
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
Why not start at the other end. What is it you are trying to achieve? What does your business need?
Improved staff retention, better skills to get better results, what ever it needs find that out first. Then start thinking about the solut
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ion.
Here are some questions you should be asking yourself
How does your organisation currently identify a training need? Who identifies the need and who is it communicated to and how is it communicated? Once identified how is that need m
Here are some questions you should be asking yourself
How does your organisation currently identify a training need? Who identifies the need and who is it communicated to and how is it communicated? Once identified how is that need m
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
t, do you look for the most convenient and cost effective course and supplier, do you select the course which uses the latest trend and buzz words or do you select the one that is the closest match to the need you have identified?
Once the
Once the
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
training has taken place what processes have been put into place to integrate the new learning into the business and to radiate it out into the wider organisation as is necessary?
However you currently manage this process the key is how e
However you currently manage this process the key is how e
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ffective is it, who benefits from the training and development - the individual, their team or the organisation. If the answer is not all three then the process you currently follow does not add true value.
More importantly do you have a w
More importantly do you have a w
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ay of measuring it? If you don't know what you want to achieve how will know if it works.
The Jedi way is to begin with the end in mind. Before a training need is identified time must be invested to find the true business or personal objec
The Jedi way is to begin with the end in mind. Before a training need is identified time must be invested to find the true business or personal objec
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
tive. Only then can the exact purpose for the training be agreed, how will it benefit not just the individual but the wider organisation. What outcome is to be achieved and how will this be measured and implemented. Will a training course b
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
the best solution, if so which one and for whom. We would challenge that it is not important what the course is called and what technique the provider uses - the only important question is will it enable you to achieve the outcome you need
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
.
76% of training doesn't work. It is a convenient distraction and provides a welcome relief from the rigours of "real life".
To change this you must have processes in place to integrate the learning into the workplace after the initial i
76% of training doesn't work. It is a convenient distraction and provides a welcome relief from the rigours of "real life".
To change this you must have processes in place to integrate the learning into the workplace after the initial i
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
nput. This starts before the training begins by making sure it is relevant and supports your business objectives and only finishes when the knowledge and skills that were trained in are habits and common place in the business. Too many time
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
s in organisations we hear yes I attended this course, I even have a certificate, but I never had time to put it into practice or it turned out that wasn't the right course for what I needed.
Training courses and workshops don't work, Peop
Training courses and workshops don't work, Peop
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
le do. There is no greater waste than that of human potential and unused knowledge.
"To know and not to do is not to know" George K Hardey When you know you are getting a return on your spend that is an investment
"To know and not to do is not to know" George K Hardey When you know you are getting a return on your spend that is an investment
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/271/justotherarticles-Training--Cost-or-Investment.html">Training - Cost or Investment?</a>
BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/271/justotherarticles-Training--Cost-or-Investment.html]Training - Cost or Investment?[/url]
Related Articles:
You're Fired! Tips for Avoiding the Termination Blues
eRecording: The Future of Document Recording
Communication Skills - Say What You Mean and Mean What You Say
Bookmark it:
|